Rights and permissions
About this article
Cite this article
Vitespen vaccine reduces risk of renal cancer recurrence. Inpharma Wkly. 1589, 7 (2007). https://doi.org/10.2165/00128413-200715890-00020
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-200715890-00020